0000919574-15-008551.txt : 20151207 0000919574-15-008551.hdr.sgml : 20151207 20151207105456 ACCESSION NUMBER: 0000919574-15-008551 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151203 FILED AS OF DATE: 20151207 DATE AS OF CHANGE: 20151207 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celator Pharmaceuticals Inc CENTRAL INDEX KEY: 0001327467 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 303B COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 243-0123 MAIL ADDRESS: STREET 1: 303B COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morenstein Scott D CENTRAL INDEX KEY: 0001576113 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36179 FILM NUMBER: 151271691 MAIL ADDRESS: STREET 1: C/O CAXTON ALTERNATIVE MANAGEMENT LP STREET 2: 1330 SIXTH AVENUE, 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 4 1 p6926191.xml OWNERSHIP DOCUMENT X0306 4 2015-12-03 0 0001327467 Celator Pharmaceuticals Inc CPXX 0001576113 Morenstein Scott D C/O CAXTON ALTERNATIVE MANAGEMENT LP 1330 SIXTH AVENUE, 20TH FLOOR NEW YORK NY 10019 1 0 0 0 Common Stock 2015-12-03 4 P 0 5000 1.865 A 6277 D This constitutes the weighted average purchase price. The prices range from $1.85 to $1.8693. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. These securities are owned by Scott D. Morenstein, who is the Reporting Person. The 1,123,612 shares of common stock previously reported on the Reporting Person's Form 4 are no longer being included because the Reporting Person does not have beneficial ownership of these securities. /s/ Scott D. Morenstein 2015-12-07